Towards clinical translation of gene editing technologies for empowering adoptive immunotherapy or correcting inherited mutations

被引：0
|
作者：
Genovese, P. [1 ]
机构：
[1] San Raffaele Telethon Inst Gene Therapy, SR Tiget, Milan, Italy
来源：
HUMAN GENE THERAPY | 2016年 / 27卷 / 11期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
OR63
引用
收藏
页码：A45 / A45
页数：1
相关论文
共 50 条
  • [31] Advancements in pre-clinical development of gene editing-based therapies to treat inherited retinal diseases
    Chirco, Kathleen R.
    Martinez, Cassandra
    Lamba, Deepak A.
    VISION RESEARCH, 2023, 209
  • [32] Immune Specific and Tumor-Dependent mRNA Vaccines for Cancer Immunotherapy: Reprogramming Clinical Translation into Tumor Editing Therapy
    Katopodi, Theodora
    Petanidis, Savvas
    Grigoriadou, Eirini
    Anestakis, Doxakis
    Charalampidis, Charalampos
    Chatziprodromidou, Ioanna
    Floros, George
    Eskitzis, Panagiotis
    Zarogoulidis, Paul
    Koulouris, Charilaos
    Sevva, Christina
    Papadopoulos, Konstantinos
    Roulia, Panagiota
    Mantalovas, Stylianos
    Dagher, Marios
    Karakousis, Alexandros Vasileios
    Varsamis, Nikolaos
    Vlassopoulos, Konstantinos
    Theodorou, Vasiliki
    Mystakidou, Chrysi Maria
    Katsios, Nikolaos Iason
    Farmakis, Konstantinos
    Kosmidis, Christoforos
    PHARMACEUTICS, 2024, 16 (04)
  • [33] The road ahead: working towards effective clinical translation of myocardial gene therapies
    Katz, Michael G.
    Fargnoli, Anthony S.
    Williams, Richard D.
    Bridges, Charles R.
    THERAPEUTIC DELIVERY, 2014, 5 (01) : 39 - 51
  • [34] Enhancing cholangiocarcinoma immunotherapy with adoptive T cells targeting HLA-restricted neoantigen peptides derived from driver gene mutations
    Panya, Aussara
    Thepmalee, Chutamas
    Sawasdee, Nunghathai
    Saengmuang, Sasithorn
    Luangwattananun, Piriya
    Yenchitsomanus, Pa-thai
    BIOMEDICINE & PHARMACOTHERAPY, 2023, 168
  • [35] CRISPR/Cas9 gene-editing: Research technologies, clinical applications and ethical considerations
    Memi, Fani
    Ntokou, Aglaia
    Papangeli, Irinna
    SEMINARS IN PERINATOLOGY, 2018, 42 (08) : 487 - 500
  • [36] A CRISPR approach for a common inherited disease: Researchers at duke university hope gene editing can eliminate mutations that lead to duchenne muscular dystrophy
    Mertz L.
    Mertz, Leslie (lmertz@nasw.org), 2018, Institute of Electrical and Electronics Engineers Inc., United States (09) : 12 - 14
  • [37] Developing Allele-Specific Gene Editing Technologies for Silencing or Precise Correction of GFAP Mutations Causing Alexander's Disease
    Meneghini, Vasco
    Gallorini, Serena
    Zambonini, Giada
    Gritti, Angela
    MOLECULAR THERAPY, 2022, 30 (04) : 300 - 300
  • [38] ANALYSIS OF A LARGE SERIES OF INHERITED AXONAL NEUROPATHIES DUE TO MITOFUSIN 2 GENE MUTATIONS: A CLINICAL POINT OF VIEW
    Piscosquito, G.
    Moroni, I
    Milani, M.
    Saveri, P.
    Baratta, S.
    Taroni, F.
    Pareyson, D.
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2013, 18 : 25 - 25
  • [39] Cytokine-induced killer (CIK) cells, successes and challenges: report on the first international conference dedicated to the clinical translation of this unique adoptive cell immunotherapy
    Sharma, Amit
    Ren, Xiubao
    Rosato, Antonio
    Sangiolo, Dario
    Wang, Zibing
    Tettamanti, Sarah
    Zhang, Yi
    Rettinger, Eva
    Fenix, Kevin Aaron
    Sommaggio, Roberta
    Cappuzzello, Elisa
    Schmidt-Wolf, Ingo G. H.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2024, 73 (02)
  • [40] Cytokine-induced killer (CIK) cells, successes and challenges: report on the first international conference dedicated to the clinical translation of this unique adoptive cell immunotherapy
    Amit Sharma
    Xiubao Ren
    Antonio Rosato
    Dario Sangiolo
    Zibing Wang
    Sarah Tettamanti
    Yi Zhang
    Eva Rettinger
    Kevin Aaron Fenix
    Roberta Sommaggio
    Elisa Cappuzzello
    Ingo G. H. Schmidt-Wolf
    Cancer Immunology, Immunotherapy, 73
12345